• Loading stock data...
Est. 2004

LEVERAGE OUR MASSIVE INVESTOR AUDIENCE!

Stock Investors · Accredited Investors · Hedge Fund Investors

Learn More or Call (407) 374-6986

Friday 11/16/2018
SMALL CAP MARKET NEWS

We release small market news updates daily, 5 times a week! Always check back to get the inside scoop on what going on.


LEVERAGE OUR MASSIVE INVESTOR AUDIENCE!

Stock Investors · Accredited Investors · Hedge Fund Investors

Learn More

vacation club

  • 5:51 PM

    OXFORD, Connecticut, January 8, 2016, NXTD, /PRNewswire/ — Nxt-ID, Inc. (NASDAQ: NXTD), a company focused on the growing m-commerce market and WorldVentures®, a privately held leading direct seller of vacation and entertainment club memberships and an Inc. 5000 fastest-growing company announced that on December 31, 2015, that WorldVentures completed a strategic investment of $2 million in Nxt-ID to develop a proprietary new wireless smart card for its members based on Nxt-ID’s Wocket®, a unique smart wallet that serves to securely

    Read more
  • Flasr - Ticker
    8:26 PM

    “New To The Street” Announces Upcoming Episodes in Top 2 Markets and Line-Up for Its July & August Shoots NEW YORK, NY–(Marketwired – Jul 16, 2015) – “New To The Street” will be broadcasting its latest show in the top 2 markets, New York on July 30th at 8:00am and LA on July 31st at 8:00am, reaching over 11M households. Check your local listings or for a full listing of stations, please go to NewToTheStreet.com and hit the “Schedule” link,

    Read more
  • 4:35 PM

    May 09, 2014 (ACCESSWIRE via COMTEX) — Whitefish, MT / May 9, 2014 / Biotechnology stocks have had a rough quarter, with the iShares NASDAQ Biotechnology Index ETF (NASDAQ: IBB) falling more than 6% since February. Investors have started to re-evaluate the sector’s lofty valuations, while higher interest rates in the near future could slow the M&A frenzy. As a result, investors may want to shift their attention to high-growth bargains in the industry. Premier Biomedical Inc. (OTC: BIEI), a

    Read more
  • 4:54 PM

    http://www.publicwire.com EL PASO, Texas, Apr 02, 2014 (BUSINESS WIRE) — Premier Biomedical, Inc. (OTCBB:BIEI), a biopharmaceutical company focused on developing and commercializing innovative immune-system manipulation therapies, has prepared and will file a provisional patent application for an anti-breast cancer treatment methodology protocol, in conjunction with its partners in R&D at the Department of Defense (DOD) with Center of Expertise at the William Beaumont Army Medical Center and the University of Texas at El Paso (UTEP) covering its study accepted for

    Read more
  • 10:35 AM

    Premier Biomedical (PublicWire.com Press Release) —Premier Biomedical, Inc. (OTCQB: BIEI) today announced that President and Chief Executive Officer, William A. Hartman, was recently interviewed for a second time in 16 months by CEO/CFO Magazine, an independent investment publication which conducts interviews with company CEOs. The latest William Hartman interview appears in the publication’s Biotechnology and Pharmaceuticals Report available by calling (570) 851-1745 or via CEO/CFO Magazine Online (http://www.ceocfointerviews.com). (The original interview was in the October, 2012 edition.) In the interview,

    Read more
Public Wire Banner